Aram Hong
CEO & Co-founder
Needle-free continuous glucose monitoring using Raman spectroscopy
Apollon develops needle-free, consumable-free continuous glucose monitors powered by targeted Raman spectroscopy. Teams in Boston and Seoul work on wearable form factors intended to measure glucose through the skin without needles. The company has published clinical feasibility work with MIT collaborators and is building toward FDA pathways. Co-founded by Aram Hong (CEO), Miyeon Jue, PhD (CTO), and Jun Ki Kim, PhD.